Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,684 | 533 | 91.2% |
| Travel and Lodging | $716.67 | 2 | 7.5% |
| Education | $76.49 | 1 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42.85 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $1,403 | 26 | $0 (2023) |
| UCB, Inc. | $730.54 | 50 | $0 (2023) |
| Gilead Sciences, Inc. | $492.19 | 4 | $0 (2019) |
| GENZYME CORPORATION | $483.26 | 26 | $0 (2022) |
| Eisai Inc. | $479.08 | 29 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $458.34 | 31 | $0 (2023) |
| Allergan, Inc. | $447.69 | 35 | $0 (2022) |
| Amgen Inc. | $439.20 | 25 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $423.73 | 25 | $0 (2023) |
| ABBVIE INC. | $371.72 | 30 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.99 | 2 | Neurelis, Inc. ($18.97) |
| 2023 | $1,011 | 52 | Teva Pharmaceuticals USA, Inc. ($137.35) |
| 2022 | $1,508 | 96 | UCB, Inc. ($171.08) |
| 2021 | $1,427 | 102 | AbbVie Inc. ($196.27) |
| 2020 | $604.00 | 48 | Allergan, Inc. ($158.68) |
| 2019 | $1,610 | 96 | UCB, Inc. ($230.98) |
| 2018 | $1,078 | 70 | Gilead Sciences, Inc. ($122.09) |
| 2017 | $2,244 | 73 | LivaNova USA, Inc. ($1,084) |
All Payment Transactions
539 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: EPILEPSY | ||||||
| 09/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.02 | General |
| 11/14/2023 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Neuroscience | ||||||
| 11/13/2023 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Neurology | ||||||
| 10/25/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: UPLIZNA | ||||||
| 10/23/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: PAIN | ||||||
| 10/17/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Neurology | ||||||
| 09/28/2023 | MDD US Operations, LLC | APOKYN (Drug) | Food and Beverage | Cash or cash equivalent | $19.84 | General |
| Category: NEUROLOGY | ||||||
| 09/22/2023 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $76.49 | General |
| 09/21/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Central Nervous System | ||||||
| 09/19/2023 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neuroscience | ||||||
| 09/19/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $13.31 | General |
| 09/14/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: EPILEPSY | ||||||
| 09/14/2023 | Catalyst Pharmaceuticals, Inc. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.59 | General |
| Category: SLEEP MEDICINE | ||||||
| 09/11/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: UPLIZNA | ||||||
| 08/24/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Central Nervous System | ||||||
| 08/23/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $17.30 | General |
| 08/21/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/17/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Neurology | ||||||
| 08/16/2023 | Aprecia Pharmaceuticals, LLC | Spritam (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Decrease CNS Disorganized Electrical Activity [PE] | ||||||
| 08/14/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Neurology | ||||||
| 07/27/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 273 | 295 | $59,163 | $24,527 |
| 2022 | 7 | 288 | 369 | $62,543 | $28,459 |
| 2021 | 7 | 414 | 513 | $96,734 | $43,812 |
| 2020 | 11 | 343 | 425 | $74,156 | $33,080 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 106 | $16,432 | $8,278 | 50.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $18,265 | $6,288 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 55 | $5,686 | $3,213 | 56.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $6,528 | $2,297 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 15 | $3,222 | $1,906 | 59.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 17 | 17 | $5,355 | $1,453 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,167 | $721.82 | 33.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 13 | 13 | $1,508 | $371.03 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 181 | $24,435 | $15,154 | 62.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 66 | $5,940 | $3,971 | 66.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 40 | 46 | $15,594 | $3,618 | 23.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 28 | 28 | $8,820 | $1,967 | 22.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $2,730 | $1,793 | 65.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,704 | $1,401 | 51.8% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 20 | 20 | $2,320 | $555.08 | 23.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 240 | $32,400 | $20,359 | 62.8% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 67 | 71 | $24,069 | $6,674 | 27.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 48 | 48 | $9,984 | $4,987 | 49.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 36 | $6,552 | $4,751 | 72.5% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 49 | 49 | $15,435 | $4,301 | 27.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 29 | $3,654 | $1,562 | 42.8% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Facility | 2021 | 40 | 40 | $4,640 | $1,178 | 25.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 138 | 202 | $27,270 | $14,967 | 54.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 26 | 26 | $8,944 | $3,952 | 44.2% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2020 | 32 | 32 | $10,080 | $2,628 | 26.1% |
About Dr. Jesse Li, MD
Dr. Jesse Li, MD is a Neurology healthcare provider based in Danville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568415263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesse Li, MD has received a total of $9,520 in payments from pharmaceutical and medical device companies, with $36.99 received in 2024. These payments were reported across 539 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($8,684).
As a Medicare-enrolled provider, Li has provided services to 1,318 Medicare beneficiaries, totaling 1,602 services with total Medicare billing of $129,878. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine, Neurology
- Location Danville, IN
- Active Since 05/17/2006
- Last Updated 11/07/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1568415263
Products in Payments
- VNS Therapy (Device) $1,308
- Briviact (Drug) $404.87
- Fycompa (Drug) $404.14
- AUBAGIO (Drug) $368.02
- Aimovig (Biological) $354.94
- UBRELVY (Drug) $320.83
- APTIOM (Drug) $319.20
- EMGALITY (Drug) $262.62
- Vimpat (Drug) $238.49
- BOTOX (Biological) $220.42
- AIMOVIG (Biological) $191.77
- UPLIZNA (Drug) $138.38
- KESIMPTA (Drug) $134.36
- MIGRANAL (Drug) $126.50
- NUEDEXTA (Drug) $125.29
- Vemlidy (Drug) $125.00
- AJOVY (Biological) $121.35
- Ponvory (Drug) $118.60
- POMPE - DISEASE (Drug) $115.24
- NURTEC ODT (Drug) $110.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Danville
Dr. Anne Morse, Do, DO
Neurology — Payments: $431,331
Dr. Justin Chandler, Md, MD
Neurology — Payments: $50,350
Dr. Said Ibrahimi, M.d, M.D
Neurology — Payments: $37,110
Victor Owusu-Yaw, M.d, M.D
Neurology — Payments: $22,929
Joshua Neucks, Md, MD
Neurology — Payments: $5,271
Prateeka Koul, Md, MD
Neurology — Payments: $3,815